SCHEMBL8637270

SCHEMBL8637270

O=C(O)CCC1(Cc2ccccc2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HDAC3 O15379 1/20 0.43
MAPK1 P28482 1/20 0.43
ADRA1A P35348 1/20 0.43
HDAC4 P56524 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
FFAR1 O14842 1/20 0.43
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648834 0.80 MAOA (0.44) SMN1; SMN2NPC1RAB9AMAOAMAOB
SCHEMBL156160 0.79 MAOA (0.54) SMN1; SMN2NPC1RAB9AMAOAMAOB
SCHEMBL7166167 0.79 GAA (0.49) SMN1; SMN2MAPK1MAPTMAOAMAOB
SCHEMBL9465836 0.77 ALDH1A1 (0.52) SMN1; SMN2MAPK1MAPTKMT2AHSD11B1
SCHEMBL7810604 0.77 MAOA (0.44) SMN1; SMN2NPC1RAB9AMAOAMAOB
SCHEMBL9181453 0.76 KMT2A (0.41) SMN1; SMN2NPC1RAB9AMAOAMAOB
SCHEMBL4904341 0.76 GAA (0.52) SMN1; SMN2NPC1RAB9AMAPTMAOA
SCHEMBL7384480 0.75 NPC1 (0.41) KEAP1SMN1; SMN2NPC1RAB9AHDAC3
SCHEMBL7818237 0.75 GAA (0.43) SMN1; SMN2NPC1RAB9AMAOAMAOB
SCHEMBL8347115 0.75 MAOA (0.54) SMN1; SMN2NPC1RAB9AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1064356-C New Piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds, process for preparation thereof and pharmaceutical compositions containing them ADIR (FR) 2001-04-11 CN disclosed
US-5753662-A TREATING DOPAMINERGIC SYSTEM DISORDERS ADIR ET COMPAGNIE (FR) 1998-05-19 US disclosed
US-5684020-A ANTIPSYCHOTICS, ANTIDEPRESSANTS, TREATMENT OF DYSFUNCTION OF DOPAMINERGIC SYSTEM ADIR ET COMPAGNIE (FR) 1997-11-04 US disclosed
CN-1142494-A New Piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds, process for preparation thereof and pharmaceutical compositions containing them ADIR (FR) 1997-02-12 CN disclosed
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed